# US 2025/0145656 A1 · Method for producing oligonucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0145656 A1
- Document ID: US20250145656A1
- Status: Published application
- Kind: A1
- Application number: 18/835,699
- Filed: 2023-02-06
- Published: 2025-05-08
- Earliest claimed: 2022-02-04
- Assignees: Nitto Denko Corporation
- Applicants: Nitto Denko Corporation
- Inventors: Kei YOSHIDA; Tomoyoshi IIDA; Masafumi IWAMOTO; Eri MAETA; Jun MATSUNAMI
- Web page: https://patentgrep.com/patent/US20250145656A1

## CPC

- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H 21/04: with deoxyribosyl as saccharide radical
- C07H 1/02: Phosphorylation
- C07H 21/02: with ribosyl as saccharide radical
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Provided herein is a method for producing oligonucleotides, that curbs the amount of nucleoside phosphoramidites remaining in a reaction container in a synthesis step, and that reduces the usage amount of nucleoside phosphoramidites. This method for producing oligonucleotides includes: (a) detaching a protecting group from a protected nucleoside that is directly or indirectly supported on a carrier and that has the protecting group bonded to a hydroxyl group, a thiol group, or an amino group located at the 3′-position or the 5′-position; (b) in the presence of an activating reagent, forming a bond between a nucleoside phosphoramidite and the hydroxyl group, the thiol group, or the amino group located at the 3′-position or the 5′-position of the nucleoside from which the protecting group had been detached and which is directly or indirectly supported on the carrier; (c) sulfurizing or oxidizing the bond formed in the step (b); and (d) capping an unbound hydroxyl group, thiol group, or amino group located at the 3′-position or the 5′-position in the nucleoside directly or indirectly supported on the carrier.

## Claims

### Claim 1

A method for producing an oligonucleotide, comprising:
(a) removing a protecting group from a protected nucleoside(s) which is directly or indirectly attached to supports and in which the protecting group is bonded to a hydroxy group, a thiol group, or an amino group at the 3′ position or the 5′ position;
(b) binding a nucleoside phosphoramidite(s) to the hydroxy group, the thiol group, or the amino group at the 3′ position or the 5′ position of the nucleoside(s) from which the protecting group has been removed and which is directly or indirectly attached to the supports in the presence of an activator(s);
(c) sulfurizing or oxidizing the bond formed in said (b); and
(d) capping the unbonded hydroxy group, thiol group, or amino group at the 3′ position or the 5′ position of the nucleoside(s) which is directly or indirectly attached to the supports,
wherein a temperature of a solution in any of said (a) to (d) is 5 to 19° C.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the amount of the nucleoside phosphoramidite(s) used in said (b) is 1.0 to 2.0 equivalents of the nucleoside(s) attached to the supports.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the temperature of a solution in any of said (a) to (d) is 5 to 15° C.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the activator(s) is selected from the group consisting of 4,5-dicyanoimidazole, 5-(ethylthio)-1H-tetrazole, 5-(benzylthio)-1H-tetrazole, and saccharin 1-methylimidazole.
